Skip to main content
. 2019 Sep 10;14(9):e0222229. doi: 10.1371/journal.pone.0222229

Fig 4. Forest plot of comparison.

Fig 4

Doultegravir vs comparators, outcome: VL<50 copies at 48 weeks.